2012 Events and Speaking Engagements
Formulation Development Course - Fundamentals of Nanomedicine
Organization: Wolfe Laboratories, Inc.
Location: Wolfe Laboratories' facility
134 Coolidge Avenue
Watertown, MA 02472
Date: November 8, 2012; 8:00am - 6:00pm
Program: This course is the latest in a series we started a few years ago, and it is intended to provide a foundation for people who are involved in early drug development.
Nanotechnology presents attractive solutions for the development of stable, commercially viable pharmaceutical products. Every nanoscale therapeutic presents a number of unique challenges that must be appropriately understood and addressed during the formulation development process. Fundamentals of Nanomedicine is designed to impart to scientists the tools and knowledge necessary to systematically approach the development of nanomedicines.
The course will provide an overview of the nanomedicine industry and detail the development of nanoscale therapeutics including small-molecule nanocrystals, polymer-based drugs, siRNA nanoparticles, and nanoparticles for targeted drug delivery. These case studies will be used to illustrate important aspects of product development to allow scientists to gain firsthand knowledge of solutions to real-world challenges in the development of nanoscale formulations.
Attendees will include scientists (B.S.-Ph.D.) from Boston-area biopharmaceutical companies. These scientists are eager to learn practical applications so that they are better equipped to perform their job. One-on-one sessions with speakers are available on a first come, first served basis. Complimentary breakfast and lunch provided, along with two facility tours during morning and afternoon breaks. Attendees will receive booklets of the relevant course information. The event will conclude with a networking cocktail reception. Limit of 50 seats available. Cost of $85 - no refunds.
Topics: The course will cover topics such as: The State of the Nanomedicine Industry; New Challenges and Frontiers in Polymer Characterization; Oral Formulations of Small Molecule Nanocrystals; Nanoparticle Formulations of siRNA; Nanotechnology Approaches to Tumor Targeting; and Characterization of Disorder by Solid State Analytical Methods: Challenges upon Transition from Macroscopic to Nano Length Scales.
Speakers: Roy Haskell, Ph.D., Research Fellow, Discovery Pharmaceutics, Bristol-Myers Squibb; Eugene Zhorov, Ph.D.; Karen Thompson, Ph.D., Distinguished Research Investigator, Pharmaceutical Research, Merck; Muthiah Manoharan, Ph.D., Senior Vice President, Drug Discovery, Alnylam; Caroline McGregor, Ph.D., Director, Basic Pharmaceutical Sciences, Merck;
Ales Medek, Ph.D., Scientific Fellow, Vertex Pharmaceuticals
For more information: click here.
To request an invitation: e-mail firstname.lastname@example.org.
2012 AAPS Annual Meeting
Organization: American Association for Pharmaceutical Scientists
Location: McCormick Place
2301 S. Lake Shore Drive
Chicago, Illinois 60616
Date: October 14-18, 2012
Hot Topic Session: The Changing Pharmaceutical Sciences Career — Strategies for Staying Productive and Successful
Session Time: Monday, October 15, 2012, 12:00 pm - 01:15 pm
Presented by: Annette Bak,
Ph.D., Director, Formulation and Basic Pharmaceutical Sciences & Outsourcing Capability Lead, Merck; Janet Wolfe,
Ph.D., President, Wolfe Laboratories; Susan Hershenson, Ph.D., President, Pharmaceutical Transformations; and Thomas E. Prisinzano,
Ph.D., Associate Professor, Department of Medicinal Chemistry, University of Kansas
Program: The AAPS Annual Meeting and Exposition provides scientists, media, and the public with an opportunity to explore and discuss timely issues related to research and development in the pharmaceutical field. Wolfe Laboratories is participating in the APQ Graduate Student Awards and the Drug Design and Discovery (DDD) Section's Graduate Student Symposium. This program recognizes excellence in graduate education in the fields of drug design and discovery.
For more information: click here.
2012 AAPS-NERDG Annual Meeting
Organization: AAPS Northeast Regional Discussion Group (NERDG)
Location: Marriott Hotel
100 Capital Boulevard
Rocky Hill, CT 06067
Date: April 20, 2012; 8am-4pm
Round Table Session 1: Characterization and Formulation of Antibody-Drug Conjugates. Presented by: Janet Wolfe, PhD, President, Wolfe Laboratories; Palani Palaniappan, PhD, Site Head, Biologics CMC Group, Takeda Millennium; Nathan Fishkin, PhD, Research Scientist, Immunogen; and Edmund Graziani, PhD, Research Fellow, Pfizer
Round Table Session 2: The Technology and Role of Delivery-Enabling Capabilities in Pharmaceutical R&D. Presented by: David Casebier, PhD, Vice President of Pharmaceutical Sciences, Wolfe Laboratories; Jinquan Dong, PhD, Head of Pre-formulation, Biogen; Robert Garmise, PhD, Research Investigator, Bristol-Myers Squibb; and Sudhakar Garad, Ph.D. Group Head, Novartis Institute for Biomedical Research.
Program: For more than a decade, the NERDG annual meetings have provided a forum for participants to present and discuss research results in an atmosphere that is conducive to social interaction and open exchange of ideas.
2012 ACS National Spring Meeting and Exposition
Organization: American Chemical Society
Location: San Diego Convention Center
111 West Harbor Drive
San Diego, CA 92101
Date: March 25-29, 2012
Program: More than 14,000 scientists from all disciplines of chemistry are expected to attend the 243rd ACS National Meeting. The theme for this year’s meeting is: The Chemistry of Life. Wolfe Laboratories is participating in the Division for Biotechnology’s session on Biophysical and Biomolecular Processes. The session is scheduled for Monday, March 26th from 8:30am - 11:00am.This program will highlight protein characterization technologies that aid in determining protein structure, stability and dynamics.
For more information, click here.
Click here to see 2011 Events
Click here to see 2010 Events
Click here to see 2009 Events
Click here to see 2008 Events
Click here to see 2007 Events